Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Guojin Ren, Qili Zhang, Pengfei Xia, Jie Wang, Pengxia Fang, Xiaojie Jin, Xuejing Peng, Yanli Xu, Jian Zhang & Lei Zhao. (2023) Synthesis and Biological Evaluation of Gentiopicroside Derivatives as Novel Cyclooxygenase-2 Inhibitors with Anti-Inflammatory Activity. Drug Design, Development and Therapy 17, pages 919-935.
Read now
Read now
Xia Zhang, Yaru Li, Xinchen Wei, Yali Hou, Siqi Jia, Siqi Li & Xiujuan Zhao. (2021) Metabolomics analysis of the effects of quercetin on hepatotoxicity induced by acrylamide exposure in rats. Free Radical Research 55:7, pages 732-742.
Read now
Read now
Piao Zhou, Wei Shi, Xiao-Yan He, Quan-Yu Du, Fei Wang & Jing Guo. (2021) Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics. Pharmaceutical Biology 59:1, pages 1478-1487.
Read now
Read now
Articles from other publishers (54)
Maria Novella Romanelli. 2024. Metalloenzymes. Metalloenzymes
431
447
.
Chao Wang, Yujing Zhang, Tingting Zhang, Jiazhen Xu, Saisai Yan, Bing Liang & Dongming Xing. (2023) Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review. International Journal of Biological Macromolecules 253, pages 127440.
Crossref
Crossref
Liling Qin & Jianan Wu. (2023) Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles. Environmental Research 239, pages 116751.
Crossref
Crossref
Ali Aliabadi, Elham Khanniri, Mohammad Mahboubi-Rabbani & Maryam Bayanati. (2023) Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer. European Journal of Medicinal Chemistry 261, pages 115866.
Crossref
Crossref
Mohammad Mavvaji & Senem Akkoc. (2023) Recent Advances in the Anticancer Applications of Benzimidazole Derivatives. ChemistrySelect 8:35.
Crossref
Crossref
Yu Tang, Cheng Qian, Yueke Zhou, Chang Yu, Mengyao Song, Teng Zhang, Xuewen Min, Aiyun Wang, Yang Zhao & Yin Lu. (2023) Activated platelets facilitate hematogenous metastasis of breast cancer by modulating the PDGFR-β/COX-2 axis. iScience 26:9, pages 107704.
Crossref
Crossref
Bin Liu, Qingfei Meng, Xin Gao, Huihui Sun, Zhixiang Xu, Yishu Wang & Honglan Zhou. (2023) Lipid and glucose metabolism in senescence. Frontiers in Nutrition 10.
Crossref
Crossref
Mathieu P.A. Hébert, Ayyoub Selka, Andréa A. Lebel, Jérémie A. Doiron, Audrey Isabel Chiasson, Vanessa L. Gauvin, Alexis J. Matthew, Martin J.G. Hébert, Marco S. Doucet, Andrew P. Joy, David A. Barnett, Mohamed Touaibia, Marc E. Surette & Luc H. Boudreau. (2023) Caffeic acid phenethyl ester analogues as selective inhibitors of 12-lipoxygenase product biosynthesis in human platelets. International Immunopharmacology 121, pages 110419.
Crossref
Crossref
Sebastian Braun, Svetlana Paskaš, Markus Laube, Sven George, Bettina Hofmann, Peter Lönnecke, Dieter Steinhilber, Jens Pietzsch, Sanja Mijatović, Danijela Maksimović‐Ivanić & Evamarie Hey‐Hawkins. (2023) Carborane‐Based Tebufelone Analogs and Their Biological Evaluation In Vitro. ChemMedChem 18:14.
Crossref
Crossref
Sebastian Braun, Sanja Jelača, Markus Laube, Sven George, Bettina Hofmann, Peter Lönnecke, Dieter Steinhilber, Jens Pietzsch, Sanja Mijatović, Danijela Maksimović-Ivanić & Evamarie Hey-Hawkins. (2023) Synthesis and In Vitro Biological Evaluation of p-Carborane-Based Di-tert-butylphenol Analogs. Molecules 28:11, pages 4547.
Crossref
Crossref
Sandhya Chahal, Payal Rani, Kiran, Jayant Sindhu, Gaurav Joshi, Aravindhan Ganesan, Subha Kalyaanamoorthy, Mayank, Parvin Kumar, Rajvir Singh & Arvind Negi. (2023) Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective. ACS Omega 8:20, pages 17446-17498.
Crossref
Crossref
Panhong Niu, Yuelan Wu, Fanxing Zeng, Shuping Zhang, Sijin Liu & Hua Gao. (2023) Development of nanodrug-based eye drops with good penetration properties and ROS responsiveness for controllable release to treat fungal keratitis. NPG Asia Materials 15:1.
Crossref
Crossref
Mahsa Azami Movahed, Fatemeh Khadem Abbasi, Mahsa Rajabi, Niusha Abedi, Nima Naderi, Bahram Daraei & Afshin Zarghi. (2023) Design, synthesis, and biological evaluation of new 2-(4-(methylsulfonyl)phenyl)-N-phenylimidazo[1,2-a]pyridin-3-amine as selective COX-2 inhibitors. Medicinal Chemistry Research 32:5, pages 856-868.
Crossref
Crossref
Priya Singh, Deepika Singh, Pooja Srivastava, Gauri Mishra & Anjani K. Tiwari. (2023) Evaluation of advanced, pathophysiologic new targets for imaging of CNS. Drug Development Research 84:3, pages 418-447.
Crossref
Crossref
Sebastian Braun, Svetlana Paskas, Markus Laube, Sven George, Bettina Hofmann, Peter Lönnecke, Dieter Steinhilber, Jens Pietzsch, Sanja S. Mijatović, Danijela Maksimović‐Ivanić & Evamarie Hey‐Hawkins. (2023) In Vitro Cytostatic Effect on Tumor Cells by Carborane‐Based Dual Cyclooxygenase‐2 and 5‐Lipoxygenase Inhibitors. Advanced Therapeutics 6:4.
Crossref
Crossref
Yinsen Song, Na Gao, Zhenzhen Yang, Sisen Zhang, Tanli Fan & Baojun Zhang. (2023) COX7B Is a New Prognostic Biomarker and Correlates with Tumor Immunity in Esophageal Carcinoma. Mediators of Inflammation 2023, pages 1-11.
Crossref
Crossref
Mohammed Hawash, Nidal Jaradat, Murad Abualhasan, Murat Kadır Şüküroğlu, Mohammed T. Qaoud, Deniz Cansen Kahraman, Heba Daraghmeh, Leen Maslamani, Mais Sawafta, Ala Ratrout & Linda Issa. (2023) Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors. BMC Chemistry 17:1.
Crossref
Crossref
Huixia Feng, Guilin Chen & Mingquan Guo. (2023) Exploring multifunctional components from Andrographis paniculata by affinity ultrafiltration with three molecular targets. Food Chemistry 404, pages 134515.
Crossref
Crossref
Mahmoud A. Ragab, Wagdy M. Eldehna, Alessio Nocentini, Alessandro Bonardi, Hazem E. Okda, Bahaa Elgendy, Tarek S. Ibrahim, Mohammad M. Abd-Alhaseeb, Paola Gratteri, Claudiu T. Supuran, Ahmed A. Al-Karmalawy & Mohamed Elagawany. (2023) 4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: Design, synthesis, and biological assessments. European Journal of Medicinal Chemistry 250, pages 115180.
Crossref
Crossref
Chao Wang, Yujing Zhang, Junwen Deng, Bing Liang & Dongming Xing. (2023) Developments of PROTACs technology in immune-related diseases. European Journal of Medicinal Chemistry 249, pages 115127.
Crossref
Crossref
Maryam Bayanati, Mona Khoramjouy, Mehrdad Faizi, Mahsa Azami Movahed, Mohammad Mahboubi-Rabbani & Afshin Zarghi. (2023) Novel Benzo[4,5]imidazo[1,2-a]pyrimidine derivatives as selective Cyclooxygenase-2 Inhibitors: Design, synthesis, docking studies, and biological evaluation. Medicinal Chemistry Research 32:3, pages 495-505.
Crossref
Crossref
Zhimin Wang, Tingting Wang, Xu Chen, Jing Cheng & Lijuan Wang. (2022) Pterostilbene regulates cell proliferation and apoptosis in non‐small‐cell lung cancer via targeting COX‐2. Biotechnology and Applied Biochemistry 70:1, pages 106-119.
Crossref
Crossref
Maryam Bayanati, Bahram Daraei & Afshin Zarghi. (2023) Design, Synthesis, Docking Studies, Enzyme Inhibitory and Antiplatelet Aggregation
Activities of New 1,3-Diphenyl-3-(Phenylthio)Propan-1-One Derivatives as Selective
COX-2 Inhibitors. Anti-Cancer Agents in Medicinal Chemistry 23:2, pages 192-200.
Crossref
Crossref
Mohammad Mahboubi-Rabbani, Maryam Abbasi & Afshin Zarghi. (2023) Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their Structural
Diversity and Mechanism of Action. Anti-Cancer Agents in Medicinal Chemistry 23:1, pages 15-36.
Crossref
Crossref
Yuandi Xiang & Qingquan Hua. (2023) The Role and Mechanism of Long Non-Coding RNA HOTAIR in the Oncogenesis, Diagnosis, and Treatment of Head and Neck Squamous Cell Carcinoma. Clinical Medicine Insights: Oncology 17, pages 117955492311690.
Crossref
Crossref
Noor Mazin Abdulkareem, Raksha Bhat, Reid T. Powell, Soumya Chikermane, Soham Yande, Lisa Trinh, Hala Y. Abdelnasser, Mantasha Tabassum, Alexis Ruiz, Mary Sobieski, Nghi D. Nguyen, Jun Hyoung Park, Camille A. Johnson, Benny A. Kaipparettu, Richard A. Bond, Michael Johnson, Clifford Stephan & Meghana V. Trivedi. (2022) Screening of GPCR drugs for repurposing in breast cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Rohini Samadarsi, Linus Augustin, Chandan Kumar & Debjani Dutta. (2022) In-silico and in-vitro studies on the efficacy of mangiferin against colorectal cancer. BMC Chemistry 16:1.
Crossref
Crossref
Ahmed M.M. Shaker, Mai I. Shahin, Asmaa M. AboulMagd, Seham A. Abdel Aleem, Hamdy M. Abdel-Rahman & Dalal A. Abou El Ella. (2022) Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2. Bioorganic Chemistry 129, pages 106143.
Crossref
Crossref
Mohammed Hawash, Nidal Jaradat, Murad Abualhasan, Mohammed T. Qaoud, Yara Joudeh, Zeina Jaber, Majd Sawalmeh, Abdulraziq Zarour, Ahmed Mousa & Mohammed Arar. (2022) Molecular docking studies and biological evaluation of isoxazole-carboxamide derivatives as COX inhibitors and antimicrobial agents. 3 Biotech 12:12.
Crossref
Crossref
Eman F. Abdelhaleem, Asmaa E. Kassab, Hala B. El‐Nassan & Omneya M. Khalil. (2022) Recent advances in the development of celecoxib analogs as anticancer agents: A review. Archiv der Pharmazie 355:12.
Crossref
Crossref
Ahmed S. Ismael, Noha H. Amin, Mohammed T. Elsaadi & Hamdy M. Abdel-Rahman. (2022) Design, synthesis and mechanistic studies of novel imidazo[1,2-a]pyridines as anticancer agents. Bioorganic Chemistry 128, pages 106042.
Crossref
Crossref
Eman F. Abdelhaleem, Asmaa E. Kassab, Hala B. El‐Nassan & Omneya M. Khalil. (2022) Design, synthesis, and biological evaluation of new celecoxib analogs as apoptosis inducers and cyclooxygenase‐2 inhibitors. Archiv der Pharmazie 355:11.
Crossref
Crossref
Eman F. Abdelhaleem, Asmaa E. Kassab, Hala B. El-Nassan & Omneya M. Khalil. (2022) Design and Synthesis of Novel Celecoxib Analogues with Potential Cytotoxic
and Pro-apoptotic Activity against Breast Cancer Cell Line MCF-7. Medicinal Chemistry 18:8, pages 903-914.
Crossref
Crossref
Xiangka Hu, Ping Shao, Xiaojuan Liu, Ling Han, Liuming Gui, Zengxiaorui Cai, Mushuang Qi & Chunmei Dai. (2022) Study on the Anti-Inflammatory Effect and Mechanism of Yuxuebi Tablet Based on Network Pharmacology. ACS Omega 7:36, pages 32784-32794.
Crossref
Crossref
Huixia Feng, Guilin Chen, Yongli Zhang & Mingquan Guo. (2022) Potential Multifunctional Bioactive Compounds from Dysosma versipellis Explored by Bioaffinity Ultrafiltration-HPLC/MS with Topo I, Topo II, COX-2 and ACE2. Journal of Inflammation Research Volume 15, pages 4677-4692.
Crossref
Crossref
Giuseppe Gargano, Francesco Oliva, Antonio Oliviero & Nicola Maffulli. (2022) Small interfering RNAs in the management of human rheumatoid arthritis. British Medical Bulletin 142:1, pages 34-43.
Crossref
Crossref
Weihua Yu, Yongmei Tu, Zi Long, Jiangzheng Liu, Deqin Kong, Jie Peng, Hao Wu, Gang Zheng, Jiuzhou Zhao, Yuhao Chen, Rui Liu, Wenli Li & Chunxu Hai. (2022) Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development. Oxidative Medicine and Cellular Longevity 2022, pages 1-22.
Crossref
Crossref
Hua Zhang, Xiaojin Zhao, Fajun Shang, Huan Sun, Xu Zheng & Jiabin Zhu. (2022) Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells
via Downregulating NF-κB/COX-2 Signaling Pathways. Anti-Cancer Agents in Medicinal Chemistry 22:10, pages 1921-1932.
Crossref
Crossref
Mohsen Ahmadi, Sander Bekeschus, Klaus-Dieter Weltmann, Thomas von Woedtke & Kristian Wende. (2022) Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors. RSC Medicinal Chemistry 13:5, pages 471-496.
Crossref
Crossref
Deivasigamani Priya, Papichettypalle Gopinath, Loganathan Sumathi Dhivya, Anandan Vijaybabu, Manoharan Haritha, Senthilkumar Palaniappan & Muthu K. Kathiravan. (2022) Structural Insights into Pyrazoles as Agents against Anti‐inflammatory and Related Disorders. ChemistrySelect 7:5.
Crossref
Crossref
Shuangshuang Guo, Xiaojing Chen, Chuhong Guo & Wei Wang. (2022) Tumour-associated macrophages heterogeneity drives resistance to clinical therapy. Expert Reviews in Molecular Medicine 24.
Crossref
Crossref
Geeta Rai, Hiral Thacker, Doli Das & Khushbu Priya. 2022. Clinical Applications of Immunogenetics. Clinical Applications of Immunogenetics
185
218
.
Chongjun Xiao, Di Lu, Jinshuo Chen, Xiaoyan Chen, Huizhu Lin, Mudan Huang, Shimei Cheng, Yuge Wang, Qiuli Liu & Haiqing Zheng. (2021) Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease. Frontiers in Pharmacology 12.
Crossref
Crossref
Fan Wu, Guoqiang Sun, Wubin Zheng, Weiwei Tang, Ye Cheng, LiangLiang Wu, Xiao Li, Jing Tao, Shijie Ma & Hongyong Cao. (2021) circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD‐L1 through NF‐κB pathway. Journal of Clinical Laboratory Analysis 35:12.
Crossref
Crossref
Wanjun Li, Zhiwei Zhang, Baiyun Wang, Na Liang, Qier Zhou & Songkai Long. (2021) MicroRNA and cyclooxygenase-2 in breast cancer. Clinica Chimica Acta 522, pages 36-44.
Crossref
Crossref
Jadwiga Maniewska, Benita Wiatrak, Żaneta Czyżnikowska & Berenika M. Szczęśniak-Sięga. (2021) Synthesis of New Tricyclic 1,2-Thiazine Derivatives with Anti-Inflammatory Activity. International Journal of Molecular Sciences 22:15, pages 7818.
Crossref
Crossref
Cyril Sobolewski & Noémie Legrand. (2021) Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib. Biomolecules 11:7, pages 1049.
Crossref
Crossref
Fedora Grande, Francesca Giordano, Maria Antonietta Occhiuzzi, Carmine Rocca, Giuseppina Ioele, Michele De Luca, Gaetano Ragno, Maria Luisa Panno, Bruno Rizzuti & Antonio Garofalo. (2021) Toward Multitasking Pharmacological COX-Targeting Agents: Non-Steroidal Anti-Inflammatory Prodrugs with Antiproliferative Effects. Molecules 26:13, pages 3940.
Crossref
Crossref
Jiahua Cui & Jinping Jia. (2021) Natural COX-2 Inhibitors as Promising Anti-inflammatory Agents: An Update. Current Medicinal Chemistry 28:18, pages 3622-3646.
Crossref
Crossref
Mohammad Mahboubi-Rabbani & Afshin Zarghi. (2021) Lipoxygenase Inhibitors as Cancer Chemopreventives: Discovery, Recent Developments and Future Perspectives. Current Medicinal Chemistry 28:6, pages 1143-1175.
Crossref
Crossref
Zhuoya Li, Zheng Wang, Baile Shen, Chen Chen, Xiaoyun Ding & Haojun Song. (2020) Effects of aspirin on the gastrointestinal tract: Pros vs. cons (Review). Oncology Letters 20:3, pages 2567-2578.
Crossref
Crossref
Noor-ul-Amin Mohsin & Muhammad Irfan. (2020) Selective cyclooxygenase-2 inhibitors: A review of recent chemical scaffolds with promising anti-inflammatory and COX-2 inhibitory activities. Medicinal Chemistry Research 29:5, pages 809-830.
Crossref
Crossref
Nehad A. El-Sayed, Mai S. Nour, M. Alaraby Salem & Reem K. Arafa. (2019) New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies. European Journal of Medicinal Chemistry 183, pages 111693.
Crossref
Crossref
George Kallergis, Stelios Sfakianakis, Michael Zervakis & Marios Spanakis. (2019) Drugs with SMILES Similar to Coxibs. Drugs with SMILES Similar to Coxibs.